Shmagin Martin E

CIK 00014072361 companySAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001407236

Recent Transactions

25 trades

Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-18$0.09/sh+1,000→ 3,137,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-16$0.09/sh+1,000→ 3,136,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-16$0.08/sh+1,000→ 3,135,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-13$0.09/sh+1,000→ 3,134,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-11$0.09/sh+2,000→ 3,133,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-09$0.09/sh+1,000→ 3,131,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-06$0.08/sh+1,000→ 3,131,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-03-05$0.08/sh+4,000→ 3,130,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-02-25$0.12/sh+1,000→ 3,126,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-02-25$0.10/sh+1,500→ 3,125,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-02-24$0.12/sh+1,000→ 3,123,573 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-29$0.10/sh+3,000→ 3,122,573 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-29$0.13/sh+1,000→ 3,119,573 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-28$0.12/sh+5,000→ 3,116,573 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-28$0.11/sh+2,500→ 3,111,573 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-28$0.15/sh+2,000→ 3,118,573 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-28$0.14/sh+1,000→ 3,117,573 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-27$0.09/sh+5,000→ 3,099,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-27$0.10/sh+10,000→ 3,109,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-23$0.16/sh−20,000→ 3,094,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-22$0.14/sh−20,000→ 3,074,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-20$0.07/sh+50,000→ 3,014,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-20$0.45/sh+50,000→ 2,964,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-20$0.08/sh+15,000→ 3,029,073 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 Par Value
2009-01-20$0.11/sh+25,000→ 3,054,073 total

Companies

Vaneltix Pharma, Inc.
Director, Chief Financial Officer

Recent Filings

Address

C/O URIGEN PHARMACEUTICALS, INC. 27 MAIDEN LANE

SAN FRANCISCO, CA, 94108

View on SEC.gov